Considering these implications, the functional outcomes of POLE mutations detected in our proteomic analysis offer a more defined understanding of their usefulness in clinical application and their prospective contribution to the advancement of personalized medicine for individuals with endometrial cancer. Here, POLE is linked to endometrial cancer.